RE:RE:RE:RE:RE:RE:URGNfredgoodwinson wrote: Don`t want to get too gloomy Hank - the jury is still out on the ultimate results of our competitors but if Urogen`s CRs against NMIBC prove as resilient over time as theirs against UUTUC it may prove significant.
TLT`s developing ability to safely and effectively treat non-superficial cancers is their ace in the hole and to effectively refine this requires the continued input of PMH the UHN and the University of Toronto so in reality they are not going to forgo such a huge prize by moving offshore but it sure gets frustrating at times.
They may though - given the expense and the competiton - think long and hard about whether to proceed with NMIBC.
I agree. The NMIBC is just the beginning. Treating the tough cancers effectively (GBM, Esoph, Lung, Pancreatic, Sarcoma, Etc....) is what is really interesting. They can work withPMH/UHN
AND be more aggressive offshore. Get this thing moving. Folks are dying.